Jethro Johnson
OCMS Deputy Director
I am an Innovation Track Principal Investigator at the Kennedy Institute of Rheumatology and Deputy Director of the Oxford Centre for Microbiome Studies.
My research uses multi-omic and computational approaches to identify the molecular basis of host-gut microbiome interactions and understand their impact on health and disease.
In 2012 I completed a PhD in nutritional ecology at the University of Auckland, New Zealand, focussing on the effects of temperature on microbially-mediated digestion in ectothermic herbivores. I subsequently transitioned from wet to dry-lab research via an MRC career development fellowship in computational genomics, working with Professor Chris Ponting and Dr Andreas Heger at the Oxford MRC Functional Genomics Unit. As a postdoctoral research associate, I moved to the lab of Professor George Weinstock at the Jackson Laboratory for Genomic Medicine, Connecticut, USA, where I applied next-generation sequencing and computational genomic approaches to characterize the human microbiome. In particular, I focussed on the role of the microbiome in metabolic disease, working on the type 2 diabetes arm of the NIH Integrative Human Microbiome Project. I joined the Kennedy Institute in 2020 to establish my own research group and help run the OCMS.
Recent publications
Comparison of Lysis and Amplification Methodologies for Optimal 16S rRNA Gene Profiling for Human and Mouse Microbiome Studies.
Journal article
Rastegari F. et al, (2025), Int J Mol Sci, 26
Changes in intestinal permeability and gut microbiota following diet-induced weight loss in patients with metabolic dysfunction-associated steatohepatitis and liver fibrosis.
Journal article
Koutoukidis DA. et al, (2024), Gut Microbes, 16
Skin Microbiome Variation with Cancer Progression in Human Cutaneous Squamous Cell Carcinoma.
Journal article
Voigt AY. et al, (2022), J Invest Dermatol, 142, 2773 - 2782.e16
Metagenomics: a path to understanding the gut microbiome.
Journal article
Yen S. and Johnson JS., (2021), Mamm Genome, 32, 282 - 296
Longitudinal Analysis of Serum Cytokine Levels and Gut Microbial Abundance Links IL-17/IL-22 With Clostridia and Insulin Sensitivity in Humans.
Journal article
Zhou X. et al, (2020), Diabetes, 69, 1833 - 1842